297 related articles for article (PubMed ID: 27006943)
21. Metabolic syndrome X: an inflammatory condition?
Das UN
Curr Hypertens Rep; 2004 Feb; 6(1):66-73. PubMed ID: 14972097
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of protease-activated receptor 2 protects against experimental colitis.
Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis in metabolic-vascular disease.
Breier G; Chavakis T; Hirsch E
Thromb Haemost; 2017 Jun; 117(7):1289-1295. PubMed ID: 28594427
[TBL] [Abstract][Full Text] [Related]
24. Adipogenesis and fat-cell function in obesity and diabetes.
Camp HS; Ren D; Leff T
Trends Mol Med; 2002 Sep; 8(9):442-7. PubMed ID: 12223316
[TBL] [Abstract][Full Text] [Related]
25. Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release.
Romacho T; Vallejo S; Villalobos LA; Wronkowitz N; Indrakusuma I; Sell H; Eckel J; Sánchez-Ferrer CF; Peiró C
J Hypertens; 2016 May; 34(5):869-76. PubMed ID: 26895560
[TBL] [Abstract][Full Text] [Related]
26. Toll like receptor expression induced by exercise in obesity and metabolic syndrome: A systematic review.
Rada I; Deldicque L; Francaux M; Zbinden-Foncea H
Exerc Immunol Rev; 2018; 24():60-71. PubMed ID: 29461969
[TBL] [Abstract][Full Text] [Related]
27. Ectopic fat accumulation and metabolic syndrome.
Rasouli N; Molavi B; Elbein SC; Kern PA
Diabetes Obes Metab; 2007 Jan; 9(1):1-10. PubMed ID: 17199713
[TBL] [Abstract][Full Text] [Related]
28. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
Huang SC
Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
[TBL] [Abstract][Full Text] [Related]
29. Factor VIIa stimulates endothelin-1 synthesis in TNF-primed endothelial cells by activation of protease-activated receptor 2.
Sethi AS; Lees DM; Douthwaite JA; Corder R
Clin Sci (Lond); 2005 Mar; 108(3):255-63. PubMed ID: 15548135
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.
Kumar Vr S; Darisipudi MN; Steiger S; Devarapu SK; Tato M; Kukarni OP; Mulay SR; Thomasova D; Popper B; Demleitner J; Zuchtriegel G; Reichel C; Cohen CD; Lindenmeyer MT; Liapis H; Moll S; Reid E; Stitt AW; Schott B; Gruner S; Haap W; Ebeling M; Hartmann G; Anders HJ
J Am Soc Nephrol; 2016 Jun; 27(6):1635-49. PubMed ID: 26567242
[TBL] [Abstract][Full Text] [Related]
31. Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.
Li X; Tai HH
Mol Carcinog; 2014 Aug; 53(8):659-66. PubMed ID: 23475608
[TBL] [Abstract][Full Text] [Related]
32. Local and systemic functions of bone fat and its contribution to the energy metabolism--the effect of diabetes and obesity on bone.
Lecka-Czernik B
J Musculoskelet Neuronal Interact; 2008; 8(4):346-7. PubMed ID: 19147970
[No Abstract] [Full Text] [Related]
33. Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes.
Arruda AP; Hotamisligil GS
Cell Metab; 2015 Sep; 22(3):381-97. PubMed ID: 26190652
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice.
Hughes KH; Wijekoon EP; Valcour JE; Chia EW; McGuire JJ
Can J Physiol Pharmacol; 2013 Apr; 91(4):295-305. PubMed ID: 23627841
[TBL] [Abstract][Full Text] [Related]
35. Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.
Yau MK; Liu L; Lim J; Lohman RJ; Cotterell AJ; Suen JY; Vesey DA; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2016 Feb; 26(3):986-991. PubMed ID: 26725028
[TBL] [Abstract][Full Text] [Related]
36. Mapping transmembrane residues of proteinase activated receptor 2 (PAR
Suen JY; Adams MN; Lim J; Madala PK; Xu W; Cotterell AJ; He Y; Yau MK; Hooper JD; Fairlie DP
Pharmacol Res; 2017 Mar; 117():328-342. PubMed ID: 27993717
[TBL] [Abstract][Full Text] [Related]
37. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells.
Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L
J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479
[TBL] [Abstract][Full Text] [Related]
39. An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats.
Lohman RJ; Cotterell AJ; Barry GD; Liu L; Suen JY; Vesey DA; Fairlie DP
FASEB J; 2012 Jul; 26(7):2877-87. PubMed ID: 22467762
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
